Lyell Immunopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARCH VENTURE MANAGEMENT, LLC | 11/14/2025 | 2.76 M | $44.81 M | 51.54% | 18.65% |
| MWG MANAGEMENT LTD. | 11/12/2025 | 1.01 M | $16.37 M | 100.00% | 6.81% |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 11/14/2025 | 800.40 K | $13.00 M | 0.00% | 5.41% |
| VANGUARD GROUP INC | 11/07/2025 | 779.00 K | $12.65 M | 76.00% | 5.27% |
| ORLAND PROPERTIES LTD | 11/12/2025 | 754.70 K | $12.26 M | 100.00% | 5.10% |
| ALMITAS CAPITAL LLC | 11/17/2025 | 577.81 K | $9.38 M | -0.38% | 3.91% |
| FORESITE CAPITAL MANAGEMENT V, LLC | 11/14/2025 | 477.08 K | $7.75 M | 17.32% | 3.23% |
| VENBIO PARTNERS LLC | 11/14/2025 | 473.48 K | $7.69 M | 0.00% | 3.20% |
| CITADEL ADVISORS LLC | 11/14/2025 | 339.49 K | $5.51 M | 25.14% | 2.29% |
| ALPHABET INC. | 11/07/2025 | 293.26 K | $4.76 M | 0.00% | 1.98% |
| BLACKROCK, INC. | 11/12/2025 | 176.81 K | $2.87 M | 22.05% | 1.20% |
| SC CHINA HOLDING LTD | 11/14/2025 | 152.30 K | $73.10 K | 0.00% | 1.03% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 130.26 K | $2.12 M | 26.13% | 0.88% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 125.36 K | $2.04 M | 140.02% | 0.85% |
| RBF CAPITAL, LLC | 11/14/2025 | 95.63 K | $1.55 M | -4.37% | 0.65% |
| MIC CAPITAL MANAGEMENT UK LLP | 11/14/2025 | 87.03 K | $1.41 M | 0.00% | 0.59% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 79.51 K | $1.29 M | 29.28% | 0.54% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 63.99 K | $1.04 M | -4.76% | 0.43% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 51.73 K | $840.05 K | 0.00% | 0.35% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 43.80 K | $711.30 K | 0.00% | 0.30% |
| JOHNSON & JOHNSON | 11/13/2025 | 41.17 K | $668.52 K | 100.00% | 0.28% |
| MORGAN STANLEY | 11/14/2025 | 37.02 K | $601.20 K | 44.06% | 0.25% |
| STATE STREET CORP | 11/14/2025 | 33.75 K | $548.13 K | -0.28% | 0.23% |
| CANADA PENSION PLAN INVESTMENT BOARD | 11/13/2025 | 29.41 K | $477.64 K | 0.00% | 0.20% |
| NORTHERN TRUST CORP | 11/14/2025 | 28.13 K | $456.80 K | 50.87% | 0.19% |
| UBS GROUP AG | 11/13/2025 | 21.24 K | $344.97 K | -17.13% | 0.14% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 20.83 K | $338.23 K | 107.05% | 0.14% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 20.80 K | $337.79 K | -4.15% | 0.14% |
| CLARIUS GROUP, LLC | 10/14/2025 | 19.96 K | $324.12 K | 4.28% | 0.13% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 18.00 K | $292.32 K | 0.00% | 0.12% |
| CITADEL ADVISORS LLC | 11/14/2025 | 16.75 K | $272.02 K | 4.75% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 16.16 K | $262.42 K | 100.00% | 0.11% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 13.13 K | $214.00 K | -95.71% | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 12.23 K | $198.68 K | 0.00% | 0.08% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 11.39 K | $184.00 K | -58.38% | 0.08% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 10.28 K | $166.87 K | 100.00% | 0.07% |
| RANGELEY CAPITAL, LLC | 11/14/2025 | 10.00 K | $162.40 K | 100.00% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 4.68 K | $75.99 K | -80.31% | 0.03% |
| ROYAL BANK OF CANADA | 11/14/2025 | 4.19 K | $68.00 K | 100.00% | 0.03% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 11/10/2025 | 3.37 K | $54.68 K | 13.52% | 0.02% |
| FMR LLC | 11/13/2025 | 2.72 K | $44.21 K | -11.54% | 0.02% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 2.00 K | $25.66 K | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.86 K | $30.17 K | -11.65% | 0.01% |
| BARCLAYS PLC | 11/12/2025 | 1.19 K | $19.36 K | 3.20% | 0.01% |
| CITIGROUP INC | 11/10/2025 | 1.03 K | $16.73 K | -49.88% | 0.01% |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 11/03/2025 | 743 | $12.07 K | 30.35% | 0.01% |
| ADVISORS ASSET MANAGEMENT, INC. | 11/06/2025 | 567 | $9.21 K | -1.39% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 490 | $7.96 K | -85.46% | 0.00% |
| GF FUND MANAGEMENT CO. LTD. | 11/07/2025 | 413 | $6.71 K | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 355 | $5.77 K | 0.57% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lyell Immunopharma, Inc. institutional Ownership - FAQ's
During the previous two years, 88 institutional investors and hedge funds held shares of Lyell Immunopharma, Inc.. The most heavily invested institutionals were:
ARCH Venture Management, LLC: 2.76 M
MWG Management Ltd.: 1.01 M
Foresite Capital Management IV, LLC: 800,399
VANGUARD GROUP INC: 779,004
Orland Properties Ltd: 754,698
Almitas Capital LLC: 577,807
65.14% of Lyell Immunopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 47.89 M shares in the last 24 months. This purchase volume represents approximately $850.05 M in transactions.